Information: Prostate Cancer Screening

• Prostate-Specific Antigen (PSA) Test: This is a simple blood test that measures the level of a protein called PSA in your blood. Normal and cancerous prostate cells make this protein. A high PSA level might suggest cancer, but other non-cancerous conditions like an enlarged or infected prostate can also cause it to rise.
• Digital Rectal Exam (DRE): During this physical exam, a doctor inserts a gloved, lubricated finger into the rectum to feel the prostate for any unusual lumps, hardness, or changes in size. 

Neither test alone can definitively diagnose cancer; abnormal results usually lead to further tests, such as a biopsy, which is the only way to confirm a diagnosis. 

Screening can find aggressive cancers early when they are easier to treat and potentially cure, which may lower your risk of dying from prostate cancer. 

However, screening also has possible harms: 

• False-positive results: High PSA levels can occur without cancer, leading to anxiety and unnecessary follow-up tests, including biopsies.
• Overdiagnosis and Overtreatment: Many prostate cancers grow slowly and may never cause health problems or shorten your life. Screening might find these slow-growing cancers, leading to treatments (like surgery or radiation) that you may not have needed.

Treatment side effects: Treatments for prostate cancer can cause serious side effects, such as erection

There is no single “right” answer for everyone. Guidelines recommend a discussion with your primary care provider to make a shared decision based on your personal risk factors.

Generally, these factors are considered:

• Age: Discussions about screening often start around age 50 for men at average risk.
• Higher risk groups: Men at higher risk, such as African-American men or those with a family history (father or brother) of prostate cancer, may start discussing screening in their 40s.
• Overall health: Your doctor will consider your general health and life expectancy, as screening is less likely to benefit men with other serious health conditions.

Ultimately, you and your primary care provider should weigh the potential benefits of early detection against the possible harms of screening and treatment to decide if screening is right for you.